HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ian R White Selected Research

Allergens

1/2023Recurrent contact urticaria to cosmetics: An unexpected allergen.
2/2021Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015-2018.
11/2020Harnessing co-operative immune augmentation by contact allergens to enhance the efficacy of viral vaccines.
1/2020Contact Allergy-Emerging Allergens and Public Health Impact.
12/2019Allergic contact dermatitis in atopic individuals: Results of a 30-year retrospective study.
11/2014Positive patch test reactions to oxidized limonene: exposure and relevance.
10/2013Categorization of fragrance contact allergens for prioritization of preventive measures: clinical and experimental data and consideration of structure-activity relationships.
9/2013The cosmetic allergy conundrum: inference of an immunoregulatory response to cosmetic allergens.
3/2010Hairdressers with dermatitis should always be patch tested regardless of atopy status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ian R White Research Topics

Disease

34Hypersensitivity (Allergy)
05/2024 - 06/2005
18Allergic Contact Dermatitis
02/2024 - 03/2004
11Dermatitis
12/2023 - 06/2005
7Contact Dermatitis (Eczema, Contact)
05/2017 - 07/2003
3Eczema
06/2013 - 11/2009
3Perinatal Death
09/2005 - 09/2004
2Urticaria (Hives)
01/2023 - 11/2020
2Prostatic Neoplasms (Prostate Cancer)
01/2023 - 12/2022
2Panic Disorder (Panic Attack)
01/2021 - 01/2021
2Neoplasms (Cancer)
01/2020 - 09/2013
2Coronary Disease (Coronary Heart Disease)
03/2014 - 07/2009
2Cardiovascular Diseases (Cardiovascular Disease)
10/2012 - 01/2012
2Colorectal Neoplasms (Colorectal Cancer)
10/2010 - 05/2010
2Schizophrenia (Dementia Praecox)
01/2010 - 01/2008
2Premature Birth (Birth, Premature)
10/2006 - 09/2004
1Back Pain (Backache)
01/2023
1Neoplasm Metastasis (Metastasis)
01/2023
1Rheumatoid Arthritis
01/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022
1Psoriatic Arthritis
01/2022
1Axial Spondyloarthritis
01/2022
1Crohn Disease (Crohn's Disease)
01/2022
1Alopecia (Baldness)
10/2021
1Bacterial Infections (Bacterial Infection)
01/2021
1Infections
01/2021
1COVID-19
11/2020
1Hepatitis C
05/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Ovarian Epithelial Carcinoma
01/2020
1Erythema
12/2015
1Skin Diseases (Skin Disease)
01/2013
1Inflammation (Inflammations)
10/2012

Drug/Important Bio-Agent (IBA)

102-methyl-4-isothiazolin-3-oneIBA
02/2024 - 07/2013
9AllergensIBA
01/2023 - 03/2010
7Hair DyesIBA
04/2019 - 02/2007
5NickelIBA
02/2021 - 04/2012
5Tuberculin (PPD)IBA
04/2019 - 06/2009
5Petrolatum (Vaseline)FDA Link
05/2016 - 11/2006
5LimoneneIBA
05/2016 - 06/2005
4HaptensIBA
02/2021 - 11/2012
3CosmeticsIBA
01/2023 - 01/2010
3linaloolIBA
08/2019 - 11/2012
34-phenylenediamine (p-phenylenediamine)FDA Link
04/2019 - 07/2013
3Biomarkers (Surrogate Marker)IBA
09/2013 - 07/2007
3Formaldehyde (Formol)FDA Link
01/2013 - 01/2010
25-chloro-2-methyl-4-isothiazolin-3-oneIBA
02/2024 - 01/2023
2Irritants (Vesicants)IBA
12/2023 - 04/2004
2SolventsIBA
10/2023 - 06/2011
2Hormones (Hormone)IBA
01/2023 - 12/2022
2Antidepressive Agents (Antidepressants)IBA
01/2021 - 01/2021
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
06/2016 - 09/2013
2Terpenes (Terpenoids)IBA
05/2016 - 06/2005
2C-Reactive ProteinIBA
03/2014 - 10/2012
2Proteins (Proteins, Gene)FDA Link
03/2012 - 07/2007
2Dietary Fats (Dietary Fat)IBA
10/2011 - 10/2010
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2006 - 09/2004
1CyanoacrylatesIBA
05/2024
1Disinfectants (Biocides)IBA
02/2024
1SalicylatesIBA
11/2023
1MethacrylatesIBA
02/2023
1AndrogensIBA
01/2023
1Docetaxel (Taxotere)FDA Link
01/2023
1Tumor Necrosis Factor InhibitorsIBA
01/2022
1Certolizumab PegolFDA Link
01/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022
1benzyl salicylateIBA
10/2021
1nalmefene (Revex)FDA Link
07/2021
1Peruvian balsam (balsam of Peru)IBA
02/2021
1Carbapenems (Carbapenem Antibiotics)IBA
01/2021
1LatexIBA
11/2020
1Antiviral Agents (Antivirals)IBA
05/2020
1Paclitaxel (Taxol)FDA LinkGeneric
01/2020
1Carboplatin (JM8)FDA LinkGeneric
01/2020
1PlatinumIBA
01/2020
1CobaltIBA
12/2019
1SesquiterpenesIBA
12/2019
1LactonesIBA
12/2019
1priminIBA
12/2019
1MetalsIBA
12/2019
1AcrylatesIBA
09/2016
1AntioxidantsIBA
06/2016
1Brimonidine Tartrate (Alphagan)FDA LinkGeneric
12/2015
1Omeprazole (Prilosec)FDA LinkGeneric
12/2014
1Volatile Oils (Essential Oils)IBA
12/2013
1Dimethyl FumarateIBA
05/2013
1Antifungal AgentsIBA
05/2013
1ethyl 2-cyanoacrylate (Krazy glue)IBA
11/2012
1CholesterolIBA
10/2012
1HDL CholesterolIBA
10/2012
1Fibrinogen (Factor I)FDA Link
10/2012

Therapy/Procedure

3Therapeutics
01/2023 - 01/2010
3Cesarean Section (Caesarean Section)
03/2007 - 08/2005
1Eyeglasses (Spectacles)
10/2023
1Dental Bonding
02/2023
1Bed Rest (Bedrest)
01/2023
1Drug Therapy (Chemotherapy)
01/2020
1Self-Testing
02/2018
1Secondary Prevention
10/2013
1Tattooing
07/2013
1Mechanical Ventilators (Ventilator)
10/2012